Researchers from the University of Missouri School of Medicine found that a targeted gene therapy may make acute myeloid leukemia (AML) more sensitive to chemotherapy, while...
Cytological image of melanoma While FDA-approved immunotherapy combinations exist for the treatment of advanced melanoma, several studies are committed to finding more effective treatments that deliver...
This study presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting investigated the impact of nirogacestat (Ogsiveo) on ovarian function in young women...
The lack of culturally safe health screening for people who are transgender and gender diverse (TGD) is putting them at greater risk of cancer going undetected,...
Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung cancer, based on results from a...
An increasing number of young women are being diagnosed with lung cancer. According to Narjust Florez, MD, this highlights the lack of data and guidelines available...
Small cell lung cancer: © Констянтин Батыльчук- stock.adobe.com Several practice-changing abstracts were presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, and findings...
Patients with pancreatic cancer who received chemotherapy both before and after surgery experienced longer survival rates than would be expected from surgery followed by chemotherapy, according...
Credit: Kateryna Kon/Science Photo Library/Getty Images The American Society for Radiation Oncology (ASTRO) has issued new guidelines for head and neck cancer radiation therapy (RT) for...
A new study published today in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating pancreatic cancer...
When it comes to health, inequalities can be seen at every level for women with breast cancer: prevention, screening, diagnosis, treatment, and survival. But what about...
An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an...